ICU Medical, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ICUI research report →
About the company
ICU Medical, Inc. , operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands.
- CEO
- Vivek Jain
- IPO
- 1992
- Employees
- 15,000
- HQ
- San Clemente, CA, US
Price Chart
- Market Cap
- $3.87B
- P/E
- 82.87
- P/S
- 1.80
- P/B
- 1.82
- EV/EBITDA
- 18.75
- Div Yield
- 0.00%
- Gross Margin
- 36.36%
- Op Margin
- 3.72%
- Net Margin
- 2.15%
- ROE
- 2.19%
- ROIC
- 2.27%
- Revenue
- $2.23B · -6.38%
- Net Income
- $732.00K · 100.62%
- EPS
- $0.03 · 100.61%
- Op Income
- $106.95M
- FCF YoY
- -26.36%
- 52W High
- $160.29
- 52W Low
- $107.00
- 50D MA
- $132.43
- 200D MA
- $135.57
- Beta
- 0.76
- Avg Volume
- 298.47K
Get TickerSpark's AI analysis on ICUI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 22, 26 | Woolson Daniel | sell | 2,123 |
| May 14, 26 | Sanzone Virginia Ruth | sell | 2,447 |
| May 13, 26 | KENNEDY KOLLEEN T | other | 1,254 |
| May 13, 26 | KENNEDY KOLLEEN T | other | 1,475 |
| May 13, 26 | KENNEDY KOLLEEN T | other | 1,254 |
| May 13, 26 | Hernandez Laurie | other | 1,254 |
| May 13, 26 | Hernandez Laurie | other | 1,475 |
| May 13, 26 | Hernandez Laurie | other | 1,254 |
| May 13, 26 | FINNEY ELISHA W | other | 1,254 |
| May 13, 26 | FINNEY ELISHA W | other | 1,475 |
Our ICUI coverage
Recent articles, reports, and earnings notes.
No research on ICUI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ICUI report →Similar companies
Peers in the same neighborhood.